Názory k článku Ministerstvo povolilo podávat pacientům s covidem ivermektin, důkazy o jeho účinku nemá
-
Skoda, ze data rikaji neco jineho. I v tom Lancetu, ktery linkujes.
Ano, je mozne, ze to nejak muze fungovat. Ale zatim plati, ze cim lepe udelana studie, tim mensi podpora ve vysledcich. Najake kovbojske nasazeni bez metodiky... "je to super". Pak to udelas poradne... a "sem tam malicko, kdyz primourime p".
-
taky skoro doktor (neregistrovaný)
The positive signal found in this pilot warrants the conduction oflarger trials using ivermectin for the early treatment of COVID-19.Such trials should include patients with risk factors for severe diseaseas well as patients with pneumonia. The potential for a mechanism ofaction different to direct antiviral effect also opens the door for pre-exposure prophylaxis in high-risk group
ČLÁNKY DO MAILU